Rottlerin potentiates camptothecin-induced cytotoxicity in human hormone refractory prostate cancers through increased formation and stabilization of topoisomerase I-DNA cleavage complexes in a PKC未-independent pathway

详细信息	查看全文 | 推荐本文 |

• 作者：Jui-Ling Hsu^a ; Yunn-Fang Ho^a ; Tsai-Kun Li^b ; Ching-Shih Chen^c ; Lih-Ching Hsu^a ; ^{lhsu@ntu.edu.tw} ; Jih-Hwa Guh^a ; ^{jhguh@ntu.edu.tw}
• 关键词：Camptothecin ; Rottlerin ; Topoisomerase I-DNA cleavage complex ; DNA damage ; Hormone-refractory prostate cancer
• 刊名：Biochemical Pharmacology
• 出版年：2012
• 期刊代码：2_00062952
• 类别：pha
• 出版时间：1 July, 2012
• 卷：84
• 期：1
• 页码：59-67
• 文件大小：1464 K

摘要

Combination therapy, which can optimize killing activity to cancers and minimize drug resistance, is a mainstream therapy against hormone-refractory prostate cancers (HRPCs). Rottlerin, a natural polyphenolic component, synergistically increased PC-3 (a HRPC cell line) apoptosis induced by camptothecin (a topoisomerase I inhibitor). Using siRNA technique to knockdown protein kinase C-未 (PKC未), the data showed that rottlerin-mediated synergistic effect was PKC未-independent, although rottlerin has been used as a PKC未 inhibitor. Rottlerin potentiated camptothecin-induced DNA fragmentation at S phase and ATM phosphorylation at Ser¹⁹⁸¹. The effect was correlated to apoptosis (r² = 0.9). To detect upstream signals, the data showed that camptothecin acted on and stabilized topoisomerase I-DNA complex, leading to the formation of camptothecin-trapped cleavage complexes (TOP1cc). The effect was potentiated by rottlerin. To determine DNA repair capability, the time-related 纬H₂A.X formation was examined after camptothecin removal. Consequently, rottlerin significantly inhibited camptothecin removal-mediated decline of 纬H₂A.X formation at S phase, indicating the impairment of DNA repair activity in the presence of rottlerin. The combinatory treatment of camptothecin and rottlerin induced conformational change and activation of Bax and formation of truncated Bad, suggesting the contribution of mitochondria stress to apoptosis. In summary, the data suggest that rottlerin-mediated camptothecin sensitization is through the augmented stabilization of TOP1cc, leading to an increase of DNA damage stress and, possibly, an impairment of DNA repair capability. Subsequently, mitochondria-involved apoptosis is triggered through Bax activation and truncated Bad formation. The novel discovery may provide an anticancer approach of combinatory use between rottlerin and camptothecin for the treatment of HRPCs.